Quarterly report pursuant to sections 13 or 15(d)

Subsequent Events - Additional Information (Detail)

v2.4.0.6
Subsequent Events - Additional Information (Detail) (Subsequent Event, Arch Therapeutics Inc)
0 Months Ended
Apr. 19, 2013
Subsequent Event | Arch Therapeutics Inc
 
Business Acquisition, Equity Interests Issued or Issuable [Line Items]  
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares 20,000,000